To investigate the causal relationship between such neuroinflammatory responses and AD pathology, genetic and pharmacological manipulation of inflammatory components including IL-12, IL-23, TNF-α, prostaglandin E2, and cluster of differentiation (CD) 40 ligand (CD40L) has been performed in animal models of AD. The gene discussed is CD40LG; the disease is Alzheimer disease.